Arama Sonuçları - Christopher D. Gocke

Sonuçları Daraltın
  1. 1
    Cytosine Deamination Is a Major Cause of Baseline Noise in Next-Generation Sequencing

    Cytosine Deamination Is a Major Cause of Baseline Noise in Next-Generation Sequencing Yazar: Guoli Chen, Stacy Mosier, Christopher D. Gocke, Ming‐Tseh Lin, James R. Eshleman

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Do Circulating Tumor Cells, Exosomes, and Circulating Tumor Nucleic Acids Have Clinical Utility?

    Do Circulating Tumor Cells, Exosomes, and Circulating Tumor Nucleic Acids Have Clinical Utility? Yazar: Bert Gold, Milena Cankovic, Larissa V. Furtado, Frederick A. Meier, Christopher D. Gocke

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  3. 3
    The combination of FLT3 and DNA methyltransferase inhibition is synergistically cytotoxic to FLT3/ITD acute myeloid leukemia cells

    The combination of FLT3 and DNA methyltransferase inhibition is synergistically cytotoxic to FLT3/ITD acute myeloid leukemia cells Yazar: Emily Chang, Sudipto Ganguly, Trivikram Rajkhowa, Christopher D. Gocke, Mark J. Levis, Helmut König

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  4. 4
    Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer

    Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer Yazar: MICHAEL S. KOPRESKI, Floyd A. Benko, Chee Kwee, Kim Leitzel, Emad F. Eskander, Allan Lipton, Christopher D. Gocke

    Baskı/Yayın Bilgisi 1997
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  5. 5
    Mutational profiling of colorectal cancers with microsatellite instability

    Mutational profiling of colorectal cancers with microsatellite instability Yazar: Elaine I. Lin, Li‐Hui Tseng, Christopher D. Gocke, Stacy Reil, Dung T. Le, Nilofer S. Azad, James R. Eshleman

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  6. 6
    Comparison of Sanger Sequencing, Pyrosequencing, and Melting Curve Analysis for the Detection of KRAS Mutations

    Comparison of Sanger Sequencing, Pyrosequencing, and Melting Curve Analysis for the Detection of KRAS Mutations Yazar: Athanasios C. Tsiatis, Alexis Norris-Kirby, Roy G. Rich, Michael J. Hafez, Christopher D. Gocke, James R. Eshleman, Kathleen M. Murphy

    Baskı/Yayın Bilgisi 2010
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  7. 7
    Clinical detection and categorization of uncommon and concomitant mutations involving BRAF

    Clinical detection and categorization of uncommon and concomitant mutations involving BRAF Yazar: Gang Zheng, Li‐Hui Tseng, Guoli Chen, Lisa Haley, Peter B. Illei, Christopher D. Gocke, James R. Eshleman, Ming‐Tseh Lin

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  8. 8
    Non-p.V600E BRAF Mutations Are Common Using a More Sensitive and Broad Detection Tool

    Non-p.V600E BRAF Mutations Are Common Using a More Sensitive and Broad Detection Tool Yazar: Jamal Carter, Li‐Hui Tseng, Gang Zheng, Jonathan C. Dudley, Peter B. Illei, Christopher D. Gocke, James R. Eshleman, Ming‐Tseh Lin

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  9. 9
    Clinical mutational profiling and categorization of BRAF mutations in melanomas using next generation sequencing

    Clinical mutational profiling and categorization of BRAF mutations in melanomas using next generation sequencing Yazar: Parvez M. Lokhandwala, Li‐Hui Tseng, Erika F. Rodriguez, Gang Zheng, Aparna Pallavajjalla, Christopher D. Gocke, James R. Eshleman, Ming‐Tseh Lin

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  10. 10
    Cancer spectrum and outcomes in the Mendelian short telomere syndromes

    Cancer spectrum and outcomes in the Mendelian short telomere syndromes Yazar: Kristen E. Schratz, Lisa Haley, Sonye K. Danoff, Amanda L. Blackford, Amy E. DeZern, Christopher D. Gocke, Amy S. Duffield, Mary Armanios

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  11. 11
    Performance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancers

    Performance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancers Yazar: Lisa Haley, Li‐Hui Tseng, Gang Zheng, Jonathan C. Dudley, Derek A. Anderson, Nilofer S. Azad, Christopher D. Gocke, James R. Eshleman, Ming‐Tseh Lin

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  12. 12
    Loss of the mismatched human leukocyte antigen haplotype in two acute myelogenous leukemia relapses after haploidentical bone marrow transplantation with post-transplantation cyclophosphamide

    Loss of the mismatched human leukocyte antigen haplotype in two acute myelogenous leukemia relapses after haploidentical bone marrow transplantation with post-transplantation cyclo... Yazar: Shannon R. McCurdy, Brian Iglehart, Denise Batista, Christopher D. Gocke, Yi Ning, Hanna A. Knaus, Annette M. Jackson, Mary S. Leffell, Leo Luznik, Ivana Gojo

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim
    Carta
    Favorilerime ekle
    Kaydedildi:
  13. 13
    Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burden

    Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burden Yazar: Theodoros Karantanos, Shruti Chaturvedi, Evan M. Braunstein, Jerry L. Spivak, Linda Resar, Styliani Karanika, Donna M. Williams, Ophelia Rogers, Christopher D. Gocke, Alison R. Moliterno

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  14. 14
    CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma

    CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma Yazar: Rena R. Xian, Yi Xie, Lisa Haley, Raluca Yonescu, Aparna Pallavajjala, Stefania Pittaluga, Elaine S. Jaffe, Amy S. Duffield, Chad M. McCall, Shereen Gheith, Christopher D. Gocke

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  15. 15
    False Positives in Multiplex PCR-Based Next-Generation Sequencing Have Unique Signatures

    False Positives in Multiplex PCR-Based Next-Generation Sequencing Have Unique Signatures Yazar: Chad M. McCall, Stacy Mosier, Michele Thiess, Marija Debeljak, Aparna Pallavajjala, Katie Beierl, Kristen Deak, Michael Datto, Christopher D. Gocke, Ming‐Tseh Lin, James R. Eshleman

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  16. 16
    Early lymphocyte recovery after intensive timed sequential chemotherapy for acute myelogenous leukemia: peripheral oligoclonal expansion of regulatory T cells

    Early lymphocyte recovery after intensive timed sequential chemotherapy for acute myelogenous leukemia: peripheral oligoclonal expansion of regulatory T cells Yazar: Christopher G. Kanakry, Allan D. Hess, Christopher D. Gocke, Christopher J. Thoburn, Ferdynand Kos, Christian F. Meyer, Janet Briel, Leo Luznik, B. Douglas Smith, Hyam I. Levitsky, Judith E. Karp

    Baskı/Yayın Bilgisi 2010
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  17. 17
    Eosinophilic Solid and Cystic (ESC) Renal Cell Carcinomas Harbor TSC Mutations

    Eosinophilic Solid and Cystic (ESC) Renal Cell Carcinomas Harbor TSC Mutations Yazar: Doreen N. Palsgrove, Yunjie Li, Christine A. Pratilas, Ming‐Tseh Lin, Aparna Pallavajjalla, Christopher D. Gocke, Angelo M. De Marzo, Andrés Matoso, George J. Netto, Jonathan I. Epstein, Pedram Argani

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  18. 18
    Clinical Validation of KRAS, BRAF, and EGFR Mutation Detection Using Next-Generation Sequencing

    Clinical Validation of KRAS, BRAF, and EGFR Mutation Detection Using Next-Generation Sequencing Yazar: Ming‐Tseh Lin, Stacy Mosier, Michele Thiess, Katie Beierl, Marija Debeljak, Li‐Hui Tseng, Guoli Chen, Srinivasan Yegnasubramanian, Hao Ho, Leslie Cope, Sarah J. Wheelan, Christopher D. Gocke, James R. Eshleman

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  19. 19
    Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide

    Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide Yazar: Christopher G. Kanakry, David G. Coffey, Andrea Towlerton, Ante Vulic, Barry E. Storer, Jeffrey Chou, Cecilia C.S. Yeung, Christopher D. Gocke, Harlan Robins, Paul V. O’Donnell, Leo Luznik, Edus H. Warren

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  20. 20
    A next-generation sequencing–based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations

    A next-generation sequencing–based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations Yazar: Mark J. Levis, Alexander E. Perl, Jessica K. Altman, Christopher D. Gocke, Erkut Bahceci, Jason E. Hill, Chaofeng Liu, Zhiyi Xie, Andrew R. Carson, Valerie McClain, Timothy T. Stenzel, Jeffrey E. Miller

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: